Almac Targets Formidable Growth

Privately owned pharmaceutical services group Almac (Craigavon, Northern Ireland, U.K.) says it is on track to increase its sales significantly during the next few years and in the U.S. in particular. Group sales increased 16% in 2007 to £150.1 million and the company predicts that in 2008 it will increase sales by 20% to £180 million. The company’s long term goal is to build its market presence in the U.S. and the firm’s largest single capital investment for the year is a proposed $100 million project to build a new U.S. headquarters and...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers